The Lancet

Three people infected with Ebola predicted to fly from West Africa every month if no exit screening takes place

 

(October 20, 2014) – Three Ebola-infected travelers are predicted to depart on an international flight every month from any of the three countries in West Africa currently experiencing widespread Ebola virus outbreaks (Guinea, Liberia, or Sierra Leone), if no exit screening were to take place, according to new modeling research published in The Lancet. 


Dr Kamran Khan at St Michael’s Hospital in Toronto, Canada, and colleagues analysed 2014 worldwide flight schedules and historic flight itineraries of passengers from 2013 to predict expected population movements out of Guinea, Liberia, and Sierra Leone. They also used WHO Ebola virus surveillance data to model the expected number of exported Ebola virus infections and to determine how useful air travel restrictions and airport departure and arrival screening might be in controlling the spread of the deadly virus.

 

The analysis, assuming no exit screening, showed that based on current epidemic conditions and international flight restrictions to and from Guinea, Liberia, and Sierra Leone, on average, just under three (2•8) travellers infected with Ebola virus are projected to travel on an international flight every month. Although airport screening is currently in place in the locations modelled, the research draws attention to the importance of ensuring that exit screening is implemented and maintained effectively in these locations.

 

"The risk of international spread could increase significantly if the outbreak in West Africa persists and grows", says Dr Khan. "Risks to the global community would further increase if Ebola virus were to spread to and within other countries with weak public health systems"*.

 

Of the almost 500 000 travellers who flew on commercial flights out of Guinea, Liberia, or Sierra Leone in 2013, over half had destinations in five countries: Ghana (17.5%), Senegal (14.4%), UK (8.7%), France (7.1%), and Gambia (6.8%). More than 60% of travellers in 2014 are expected to have final destinations in low or lower-middle income countries. "Given that these countries have limited medical and public health resources, they may have difficulty quickly identifying and effectively responding to imported Ebola cases"*, says Dr Khan.

 

The findings also indicate that it is far more efficient and less disruptive to screen travellers for Ebola as they leave affected countries in West Africa rather than screen the same travellers as they arrive at other airports around the world. The authors also point out that with effective exit screening of travellers in place, the additional utility of entry screening is very low given the short flight durations out of affected countries, compared with the much longer incubation period of Ebola virus.

 

Dr Khan explains, "Exit screening at the three international airports (Conakry, Monrovia, and Freetown) in Guinea, Liberia, and Sierra Leone should allow all travellers at highest risk of exposure to Ebola to be assessed with greater efficiency compared with entry screening the same passengers as they arrive in cities around the world. However, this will require international support to effectively implement and maintain"*.

 

He adds, "The best approach to minimise risks to the global community is to control the epidemic at its source. While screening travellers arriving at airports outside of West Africa may offer a sense of security, this would have at best marginal benefits, and could draw valuable resources away from more effective public health interventions. Furthermore, excessive constraints on air travel could have severe economic consequences that could destabilise the region and possibly disrupt critical supplies of essential health and humanitarian services. Decision-makers must carefully balance the potential harms that could result from travel restrictions against any reductions in the risk of international spread"*.

 

Writing in a linked Comment, Dr Hongjie Yu from the Chinese Center for Disease Control and Prevention, Beijing, China and Dr Benjamin Cowling from The University of Hong Kong, China, welcome the study, which they say, "is an advance over previous work, which analysed flight networks and connectivity, but did not account for passenger flows and final destinations". However, they add that, "Some countries have implemented and will continue entry screening for various reasons. Subject to entry screening already being implemented, exit screening from the affected countries might not have incremental utility, especially considering the other urgent priorities in the region. In addition to any entry or exit screening, vigilance within countries is essential for early detection of imported cases of Ebola virus disease".

 

 

 

NOTES TO EDITORS

 

  • This study was funded by the Canadian Institutes of Health Research.
  • *Quotes direct from author and cannot be found in text of Article.

 


The Lancet, 20.10.2014 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…